Search research articles
Contact Us
Filters
Showing results (21-30 of 138) with videos related to
Page
of 14
Sort By:
Leukemia & Lymphoma
|
November 22, 2017
Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034
Carlyn Rose C Tan, Stefan K Barta, Jeannette Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team
Ariela Noy, David T Scadden, Jeannette Lee, et al.
Infectious Agents and Cancer
|
October 30, 2025
Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation
Logan George, Paul G Rubinstein, Jennifer Petr, et al.
Blood Advances
|
November 18, 2022
Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study
Shunan Qi, Xin Liu, Ariela Noy, et al.
Clinical Nuclear Medicine
|
April 30, 2020
Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up
Sonia Mahajan, Reiko Nakajima, Mariko Yabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
Heiko Schöder, Ariela Noy, Mithat Gönen, et al.
Blood
|
May 10, 2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma
Ariela Noy, Jeannette Y Lee, Ethel Cesarman, et al.
Blood
|
August 19, 2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
David J Straus, Carol S Portlock, Jing Qin, et al.
Cancers
|
January 28, 2026
Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I Study
Erel Joffe, Zachary Epstein-Peterson, Lorenzo Falchi, et al.
Leukemia & Lymphoma
|
July 16, 2005
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy
Jeffrey L Halaas, Craig H Moskowitz, Steven Horwitz, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 138) with videos related to
Sort By:
Page
of 14
Leukemia & Lymphoma
|
November 22, 2017
Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034
Carlyn Rose C Tan, Stefan K Barta, Jeannette Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team
Ariela Noy, David T Scadden, Jeannette Lee, et al.
Infectious Agents and Cancer
|
October 30, 2025
Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation
Logan George, Paul G Rubinstein, Jennifer Petr, et al.
Blood Advances
|
November 18, 2022
Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study
Shunan Qi, Xin Liu, Ariela Noy, et al.
Clinical Nuclear Medicine
|
April 30, 2020
Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up
Sonia Mahajan, Reiko Nakajima, Mariko Yabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
Heiko Schöder, Ariela Noy, Mithat Gönen, et al.
Blood
|
May 10, 2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma
Ariela Noy, Jeannette Y Lee, Ethel Cesarman, et al.
Blood
|
August 19, 2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
David J Straus, Carol S Portlock, Jing Qin, et al.
Cancers
|
January 28, 2026
Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I Study
Erel Joffe, Zachary Epstein-Peterson, Lorenzo Falchi, et al.
Leukemia & Lymphoma
|
July 16, 2005
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy
Jeffrey L Halaas, Craig H Moskowitz, Steven Horwitz, et al.
Page
of 14